Botulinum toxin (CKD Bio)

肉毒毒素 (CKD Bio)

Report date: 2024/01/23 20:00:33

Base Information

Drug NameBotulinum toxin (CKD Bio)
Drug Alias NameCKDB-501BCKDB-501-BCKDB-501ACKDB-501-ACKDB-501
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionNeuromuscular Blocking AgentsGlutamates antagonistsAcetylcholine inhibitors
TargetsGlutamatesAcetylcholinesterase
Therapy Area/IndicationsGlabellar linesSpasm
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCKD Bio Corp
China Registration ClassN/A

Develop Information

Active CompaniesCKD Bio Corp
Inactive CompaniesN/A
Active IndicationsGlabellar linesSpasm
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A